Introduction
Live-attenuated measles virus (MV) vaccines have been used successfully since the 1960s to reduce the incidence of measles. Several vaccine strains were derived from the prototype Edmonston wild-type (wt) virus, which was isolated in 1954 (Enders & Peebles, 1954) . The methods employed for attenuation involved passaging the virus in various cell culture systems at different incubation temperatures . An experimental vaccine strain, Rubeovax, which was adapted to chicken embryo fibroblasts, proved to be too reactogenic to be useful as a vaccine (McCrumb et al., 1961 ; Reilly et al., 1961) . Moraten, the vaccine strain currently used in the United States, was derived through more extensive passaging of the Edmonston virus in chicken embryo fibroblasts. It displays a stable attenuated phenotype, while still inducing a protective immune response (Hilleman et al., 1968) .
The genetic basis for the attenuation of MV vaccines remains unknown. Recently, attenuating mutations of can- didate vaccine strains of two other members of the family Paramyxoviridae, human parainfluenza virus type 3 and respiratory syncytial virus (RSV), were mapped to their L proteins (Crowe et al., 1996 ; Juhasz et al., 1997 ; Skiadopoulos et al., 1998) . Since sequence analysis of the nucleocapsid, matrix, fusion and haemagglutinin genes of MV vaccine strains did not lead to the characterization of consistent attenuation markers , it was of interest to analyse the role of the MV L protein in attenuation. L is a structural protein of 2183 amino acids (248 kDa) and an essential component of the MV replication and transcription apparatus (Blumberg et al., 1988 ; Sidhu et al., 1995) . Because of the size and the low abundance of its mRNA, the L gene remains the least studied of all MV genes and only one full-length clone of a vaccine L gene was previously available for study (Huber, 1993) .
In this study, we analysed the L gene sequences of a lowpassage seed stock of the Edmonston wt virus, the reactogenic Rubeovax strain and the Moraten vaccine strain. They were compared with the sequences of other vaccine strains, derived from the Edmonston virus or other progenitors. We put these data into context by examining the L sequences of recently isolated wt viruses, representing four different genotypes WHO, 1998) . While no consistent marker for attenuation was found, these data will provide a basis for the analysis of the activities of vaccine and wt L proteins in a functional assay. To this end, three full-length L proteins were expressed in vitro and their ability to form a complex with the MV phosphoprotein (P protein) was demonstrated.
Methods
Cells and viruses. Vero cells, CV-1 cells and primary chicken embryo fibroblasts were cultivated in Dulbecco's modified Eagle's medium supplemented with 10 % foetal calf serum, glutamine and antibiotics. The origin and passage history of the Edmonston wt virus , the Illinois-1, Gambia and Netherlands isolates (Rota et al., 1992 (Rota et al., , 1996 , the Delaware isolate and the Philadelphia-26, Halonen and China93-5 wt isolates (Rota et al., 1994 b ; Xu et al., 1998) RNA preparation and RT-PCR. Total cellular RNA was extracted from MV-infected Vero cells by using the acid guanidinium-phenol method (Chomczynski & Sacchi, 1987) . Reverse transcriptase reactions were performed with an oligo(dT) primer and Superscript II reverse transcriptase (Gibco BRL). PCR was performed with the Elongase enzyme mix (Gibco BRL) according to the manufacturer's recommendations for long RT-PCR. With the exception of the Illinois-1 L gene, all L genes were amplified in two fragments. Two sets of PCR primers were designed to amplify a 3n5 kb fragment of the start of the gene and a 3n2 kb fragment of the end of the gene. Two primers were derived from the 5h and 3h non-coding region of the L gene and two primers overlapped at a unique SacI site at position 3439 of the L gene. The BamHI and SalI restriction sites, which were added to the primers to facilitate insertion of full-length L clones into pTM1, are underlined. The pTM1 plasmid was kindly provided by B. Moss. The primers were : (1) 5h CCGGATCCGGTCCAAGTGGTTCCCCG 3h (BamHI), (2) 5h GTACA-TCAGGGACCTCAAG 3h, (3) 5h GAAATGTCCTCATTGACA 3h and (4) 5h CCGGGTCGACGGATTAGGGTTCCGGAG 3h (SalI). The Illinois-1 L gene was amplified in three fragments. The primers used were : (5) 5h GATCGGATCCTATGGACTCGCTATCTG 3h (BamHI), (6) 5h GGTATGACTACATCCCGGGTCATGG 3h, (7) 5h CAATCAATT-CAACCATGACCCGGG 3h, (8) 5h GAGCATCAAGTGAAGGAC-CATGGAT 3h, (9) 5h GAGCCTATCCATGGTCCTTCACTTGA 3h and (10) 5h GGCCGGTCGACTTAGTCCTTAATCAGGG 3h (SalI). Since primers 5 and 10 bound inside the Illinois-1 L coding region, the sequences of the 5h and 3h ends of the L coding region were verified with PCR fragments generated with primers 1 and 4. Sequences of all primers were based on the Edmonston vaccine strain (Blumberg et al., 1988) . For each fragment, two independent RT-PCRs were performed with the same RNA preparation.
Sequencing. PCR fragments were cloned into pCR2.1 (Invitrogen). Clones from each separate PCR were sequenced by using T7 polymerase (Sequenase ; United States Biochemical) according to the manufacturer's protocol. The level of sequence divergence among duplicate clones was 0n15 %. Discrepancies between the two clones were resolved by sequencing a third, independently derived PCR product. Clonal analysis was chosen over direct sequencing of PCR fragments to allow assembly and expression of full-length clones. Sequencing primers based on the Edmonston strain (Blumberg et al., 1988) were constructed at 300 bp intervals along the L coding sequence. Sequence data were analysed by using version 9.1 of the sequence analysis software package of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) and version 3.5 of the Phylogeny Inference Package (Felsenstein, 1988) . For the analysis of conservative amino acid changes, amino acids were grouped into families as follows : (Phe, Tyr), (Met, Leu, Ile, Val), (Ala, Gly), (Thr, Ser), (Gln, Asn), (Glu, Asp), (Lys, Arg), (His), (Pro), (Trp) and (Cys).
L protein expression and co-precipitation. Full-length clones of the Gambia, Netherlands and Illinois-1 L genes were assembled in pTM1. When necessary, nucleotide changes in L fragments that were a consequence of polymerase errors were repaired by replacement with the correct sequence of the second clone, by using suitable restriction sites. PEMC-La, expressing the EdmBil vaccine L protein, was a gift of M. Billeter, Zu$ rich, Switzerland. The Edmonston wt P gene was amplified by RT-PCR with P gene-specific primers based on the Edmonston vaccine strain , with the same RNA preparation and RT-PCR procedures as for the L gene. The Edmonston wt P protein differs from the Edmonston vaccine sequence by four amino acid changes : 110 (Y to H), 225 (E to G), 246 (L to S) and 306 (Y to H). After sequencing, the gene was subcloned into pTM1 between the EcoRI and XhoI sites.
CV-1 cells were infected with MVAT7 at an m.o.i. of 5. One hour after infection, cells were transfected with Pfx6 (Invitrogen) in Opti-Mem (Gibco BRL) and labelled with [$&S]methionine in methionine-free medium from 6 to 10 h after transfection. Cells transfected with L alone were labelled from 9n5 to 10 h after transfection. Cell extracts were prepared in MV salts (0n1 M HEPES, pH 8n0, 50 mM NH % Cl, 7 mM KCl, 5 mM magnesium acetate) plus 0n25 % NP-40. Aliquots of the cell extracts were incubated with an L-specific rabbit antiserum or a P-specific mouse antiserum followed by precipitation with GammaBind G-Sepharose (Amersham Pharmacia Biotech). The complexes were washed with MV salts plus 0n25 % NP-40 and separated on a 7n5 % SDS-polyacrylamide gel. After electrophoresis, bands were visualized by autoradiography.
Results and Discussion

Cloning and sequencing of MV L genes
Ten MV isolates were chosen for sequence analysis (Table  1) . Edmonston wt, which was isolated in 1954 (Enders & Peebles, 1954) , was the progenitor of three vaccine strains sequenced in this study (Moraten, Edmonston-Zagreb and Rubeovax). These three vaccines have displayed varying levels of reactogenicity in humans. Rubeovax was an effective but suboptimally attenuated experimental vaccine strain that often required the administration of anti-MV immunoglobulin together with the vaccine because of its reactogenic potential (McCrumb et al., 1961 ; Reilly et al., 1961) . Moraten, the vaccine strain used in the United States (Attenuvax vaccine), and the Edmonston-Zagreb strain are safe and effective vaccines (Enders et al., 1960 ; Ikic et al., 1972) . The Leningrad- 4 strain, isolated in 1957 (Huang et al., 1962) , was reported to be the progenitor of the Changchun-47 vaccine strain (Hsin et al., 1975 ; Xiang & Chen, 1983) . All vaccine strains and their progenitors have been assigned to genotype A (WHO, 1998).
To assess the variability of recent wt isolates, the Delaware, Illinois-1, Netherlands and Gambia isolates were chosen to represent four different MV genotypes.
Nucleotide sequence analysis
L gene sequences obtained in this study were compared with those already available from GenBank. Two different sequences have been published for the Edmonston vaccine L gene, previously referred to as EdmBlu and EdmBil, which differ in six nucleotide and four amino acid positions (Komase et al., 1995) . Since the EdmBil sequence is part of the infectious MV clone and thus has proved to be functional, it was chosen for this analysis. The AIK-C strain is an Edmonston-derived, temperature-sensitive vaccine strain used in Japan (Fukuda & Sugiura, 1983 ; Mori et al., 1993) . JM and CM are wt viruses isolated in 1977 and the two SSPE (subacute sclerosing panencephalitis) L gene sequences were derived from MV RNA extracted from persistently infected brain tissue (Komase et al., 1995) . L gene sequences of genotype A viruses, both wt and vaccine, varied by no more than 0n3 % at the nucleotide level and 0n5 % at the amino acid level (Table 2 ). In contrast, the non-genotype A wt L genes were less well-conserved. The more recent wt isolates (Illinois-1, Netherlands, Gambia) displayed up to 3n2 % variability at the nucleotide level and 1n7 % at the amino acid level (Gambia vs Illinois-1). Position 6490 of the Illinois-1 L gene was either A or G in the two independently derived clones and could not be resolved by sequencing of two additional, independently derived PCR products. Although the RNA population was heterogeneous with respect to this position, substitution of either base resulted in synonymous codons. Within genotype C2 (JM, SSPE B, Netherlands), L genes were more conserved than between wt L genes of different genotypes (Table 2) . A phylogenetic analysis of the nucleotide sequences of MV L genes verified the relationships established in earlier work based on N and H genes (Rota et al., 1996 (data not shown).
When compared with Edmonston wt, the number of silent mutations was much lower in L genes of most of the genotype A viruses than in the non-genotype A L genes. While nongenotype A L genes had an average of 83 % silent mutations, genotype A L genes had an average of 57 %. The exceptions in genotype A were Leningrad-4 and Rubeovax, with 71 % and 75 % silent mutations, respectively. However, when compared with JM, all L genes showed at least 83 % silent mutations. Therefore, the difference in the percentage of silent mutations probably reflects the choice of reference strain rather than an actual biological phenomenon.
Comparison of vaccine and genotype A wt L proteins
Within genotype A, the number of conservative amino acid changes relative to Edmonston wt varied between 0 and 25 %. The L protein of the Rubeovax vaccine strain differed from the Edmonston wt L protein at two positions, 1717 and 1887, and the Moraten L protein acquired two additional changes, at positions 331 and 2114 (Table 3 ). The L proteins of the Edmonston-Zagreb and AIK-C vaccine strains shared only the change at position 1717 with the Rubeovax and Moraten strain L proteins and both Edmonston-Zagreb and AIK-C had substitutions at positions 1409 and 1649. AIK-C differed from its Edmonston wt progenitor by five additional amino acid 
Amino acid
changes, which were not observed in any of the other vaccine strains. AIK-C is the only temperature-sensitive strain among the MV vaccines (Fukuda & Sugiura, 1983) ; it is tempting to speculate that these amino acid changes might play a role it its temperature sensitivity. In addition, analysis of the L gene sequences did not identify a unique pattern of nucleotide or amino acid substitutions that could confirm that Leningrad-4 was the wt progenitor of the Changchun-47 vaccine strain (Table 3) . There were no unique amino acid substitutions that distinguished the genotype A wt L proteins (Leningrad-4, Delaware, Edmonston wt) from those of the vaccine strains (Table 3 ). Amino acid 1717 was Ala in all Edmonston-derived vaccines but Asp in the Edmonston wt L protein. This amino acid position therefore appeared to differentiate between the vaccine strains and their progenitor. However, the Delaware and Leningrad-4 wt strains and the SSPE B L proteins also contained Ala in this position, like the vaccines. To examine the significance of amino acid 1717 further, this position was analysed in the L genes of six additional genotype A wt viruses. Five of the six viruses shared Ala at amino acid 1717, while Philadelphia-26 had Asn (Table 3) . The Edmonston wt, Leningrad-4, Halonen and Romania isolates pre-date the development of live MV vaccines ; therefore, it is unlikely that these are re-isolated vaccine strains or revertants. Amino acid 1717 is located in a region of relatively low conservation (see below), which further decreases the likelihood of it having a role in attenuation. Table 4 lists the deduced amino acid variations of the nongenotype A wt L proteins. The highest percentages of conservative changes relative to the Edmonston wt L protein were found in two recent wt isolates, Illinois-1 (50 %) and Gambia (45 %), suggesting that there are strong evolutionary constraints on the L protein. These genetically divergent isolates may display the maximum amount of variability that can be tolerated in the polymerase protein.
Non-genotype A wt L proteins
There were no obvious amino acid substitutions that differentiated between all vaccines and all wt viruses. While this could suggest that the genetic basis for attenuation of MV vaccines may not be located in their L genes, studies with RSV showed that there can be multiple pathways to attenuation. Two RSV candidate vaccines, derived from a temperaturesensitive progenitor by a single round of chemical mutagenesis, were further attenuated because of single amino acid changes in different positions of the L gene of each virus (Crowe et al., 1996 ; Juhasz et al., 1997) . Given the multifunctional nature of L, it is not surprising that a variety of subtle changes can affect its activity. Unfortunately, the long and complex passage histories of the MV vaccine viruses make a direct comparison more complicated than in the case of the RSV candidate vaccines. The low-passage Edmonston wt isolate differs from the original vaccine progenitor by several passages and none of the vaccines are derived directly from one another . It is therefore likely that each vaccine strain could have acquired its own constellation of attenuating mutations at various positions in the genome. Takeda et al. (1998) recently compared an MV wt isolate grown on B95a cells, a marmoset B cell line immortalized with Epstein-Barr virus, with a variant of the same MV isolate adapted to Vero cells. These variants differed in their pathogenicity in cynomolgus monkeys and in their replicative activity in B95a cells. The authors identified adaptationinduced amino acid changes in the P protein and the L protein (aa 1248 and aa 1800). Although the majority of L gene sequences analysed in our paper were obtained from Vero cell-adapted virus stocks, all 16 of them showed amino acids corresponding to the B95a variant described in the paper by Takeda et al. (1998) . Therefore, the changes these authors observed in the L protein do not appear to be obligatory for Vero cell adaptation. At this point, we cannot distinguish between changes induced by host cell adaptation and those that result in attenuation.
Areas of conservation among MV L proteins
A comparison of L proteins of five non-segmented negative-strand RNA viruses has led to the identification of six conserved areas, which may represent functional domains (Poch et al., 1990) . Analysis of the distribution of variable positions in the MV L protein showed that these domains are not equally well conserved among MV L proteins (Fig. 1) . In agreement with the proposed domain structure, the central part of the MV L protein was highly conserved, while the carboxy terminus displayed higher variability. However, the distribution of variable positions in the amino terminus deviated from the pattern of conservation observed between non-segmented negative-strand RNA virus L proteins. For example, predicted domain I (aa 214-408) was actually more variable than its surrounding areas.
Except for three positions (aa 331, 429, 513), all amino acid variations between genotype A viruses were located near the carboxy terminus (Table 3) . Surprisingly, there was not a single change in the hinge region (aa 600-652) in genotype A L proteins, which is the most variable area in non-genotype A L proteins (Table 4) , morbillivirus L proteins (McIlhatton et al., 1997) and non-segmented negative-strand RNA virus polymerases in general (Poch et al., 1990) .
Expression of wt L proteins
The L genes of the Illinois-1, Netherlands and Gambia isolates were assembled from the cloned fragments to generate the complete open reading frames. One characteristic of the L protein is the interaction with the P protein to form a functional polymerase complex. While complex formation (Poch et al., 1990) . The variability among MV L proteins in each block is represented by the height of the bar and expressed as a percentage above the bars. does not demonstrate enzymatic activity of the cloned L proteins, it is a prerequisite for polymerase function (Horikami et al., 1994) . To test whether the three wt L proteins could bind P, co-precipitation experiments were performed. Each of the three wt L proteins and the EdmBil vaccine L protein were coexpressed with the Edmonston wt P protein. Precipitation with a P-specific antiserum co-precipitated all four L proteins, thus demonstrating complex formation (Fig. 2 a, lanes 4, 6, 8 and  10 ). L proteins expressed in the absence of P did not react with the P-specific antiserum (Fig. 2 a, lanes 3, 5, 7 and 9) . Precipitation of another aliquot of the same extracts with an Lspecific antiserum showed that L proteins were expressed both in the presence and absence of P (Fig. 2 b) . This serum did not co-precipitate P. All four L proteins formed complexes with the same P protein, suggesting that the P-binding sites are conserved between these most-divergent L proteins. The binding site for the P protein has been mapped to amino acids 1-408 of the MV L protein (Horikami et al., 1994) . This region contains only ten variable amino acid positions among these four L proteins.
Attempts to measure attenuation in vitro by assessing the plaque size or host range of MV vaccine strains have proven inconclusive (Buynak et al., 1962) . It is therefore necessary to develop biological assays to analyse the contribution of individual MV proteins to the attenuated phenotype. The development of a reverse genetics system to generate MV from cloned cDNA has opened the possibility of testing the contribution of individual MV genes to attenuation. To examine whether polymerase proteins of MV wt and vaccine viruses vary in their replicative activities, an in vivo replication assay is currently being developed. It will allow comparison of the function of MV L proteins as well as analysis of their co-operation with nucleoproteins and P proteins from the same or different MV isolates. The sequence information provided in this paper also makes it possible to generate chimeric L proteins with combinations of vaccine and wt domains and to assess their activity.
